Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 48.64
-0.33 (-0.67%)
Mar 9, 2026, 4:00 PM EDT
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 6.32 billion as of March 9, 2026. Its market cap has increased by 33.81% in one year.
Market Cap
6.32B
Enterprise Value
5.01B
Revenue
354.91M
Ranking
n/a
PE Ratio
131.46
Stock Price
48.64
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 6.32B, a decrease of -39.36%. That is a compound annual growth rate of -13.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 6.32B | 13.41% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 6.32B |
| Lifecome Biochemistry | 6.36B |
| Xiangxue Pharmaceutical | 6.21B |
| GemPharmatech | 6.21B |
| R&G PharmaStudies | 6.18B |
| Shenzhen Weiguang Biological Products | 6.65B |
| Kexing Biopharm | 5.92B |
| Jiangsu Aidea Pharmaceutical Group | 6.83B |